SG11201600786RA - Saccharide vaccine formulation - Google Patents
Saccharide vaccine formulationInfo
- Publication number
- SG11201600786RA SG11201600786RA SG11201600786RA SG11201600786RA SG11201600786RA SG 11201600786R A SG11201600786R A SG 11201600786RA SG 11201600786R A SG11201600786R A SG 11201600786RA SG 11201600786R A SG11201600786R A SG 11201600786RA SG 11201600786R A SG11201600786R A SG 11201600786RA
- Authority
- SG
- Singapore
- Prior art keywords
- vaccine formulation
- saccharide vaccine
- saccharide
- formulation
- vaccine
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1314248.4A GB201314248D0 (en) | 2013-08-08 | 2013-08-08 | Saccharide vaccine formulation |
| US201361865166P | 2013-08-13 | 2013-08-13 | |
| PCT/EP2014/066591 WO2015018753A1 (en) | 2013-08-08 | 2014-08-01 | Saccharide vaccine formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600786RA true SG11201600786RA (en) | 2016-03-30 |
Family
ID=49261915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600786RA SG11201600786RA (en) | 2013-08-08 | 2014-08-01 | Saccharide vaccine formulation |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20170119864A1 (es) |
| EP (1) | EP3030258A1 (es) |
| JP (1) | JP2016527291A (es) |
| KR (1) | KR20160040705A (es) |
| CN (1) | CN105592857A (es) |
| AR (1) | AR097188A1 (es) |
| AU (1) | AU2014304668A1 (es) |
| BE (1) | BE1022254B1 (es) |
| BR (1) | BR112016002349A2 (es) |
| CA (1) | CA2920221A1 (es) |
| GB (1) | GB201314248D0 (es) |
| IL (1) | IL243873A0 (es) |
| MX (1) | MX2016001694A (es) |
| SG (1) | SG11201600786RA (es) |
| WO (1) | WO2015018753A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101631563B (zh) * | 2007-03-09 | 2013-07-24 | 大塚制药株式会社 | 含有流感疫苗的冻干制剂及其制备方法 |
-
2013
- 2013-08-08 GB GBGB1314248.4A patent/GB201314248D0/en not_active Ceased
-
2014
- 2014-08-01 AU AU2014304668A patent/AU2014304668A1/en not_active Abandoned
- 2014-08-01 CN CN201480055311.6A patent/CN105592857A/zh active Pending
- 2014-08-01 CA CA2920221A patent/CA2920221A1/en not_active Abandoned
- 2014-08-01 WO PCT/EP2014/066591 patent/WO2015018753A1/en active Application Filing
- 2014-08-01 EP EP14747366.4A patent/EP3030258A1/en not_active Withdrawn
- 2014-08-01 US US14/910,710 patent/US20170119864A1/en not_active Abandoned
- 2014-08-01 AR ARP140102892A patent/AR097188A1/es unknown
- 2014-08-01 MX MX2016001694A patent/MX2016001694A/es unknown
- 2014-08-01 JP JP2016532336A patent/JP2016527291A/ja active Pending
- 2014-08-01 BR BR112016002349A patent/BR112016002349A2/pt not_active Application Discontinuation
- 2014-08-01 KR KR1020167006046A patent/KR20160040705A/ko not_active Application Discontinuation
- 2014-08-01 SG SG11201600786RA patent/SG11201600786RA/en unknown
- 2014-08-01 BE BE2014/0589A patent/BE1022254B1/fr not_active IP Right Cessation
-
2016
- 2016-01-28 IL IL243873A patent/IL243873A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015018753A1 (en) | 2015-02-12 |
| BE1022254B1 (fr) | 2016-03-04 |
| CA2920221A1 (en) | 2015-02-12 |
| JP2016527291A (ja) | 2016-09-08 |
| KR20160040705A (ko) | 2016-04-14 |
| BR112016002349A2 (pt) | 2017-08-01 |
| EP3030258A1 (en) | 2016-06-15 |
| IL243873A0 (en) | 2016-04-21 |
| AU2014304668A1 (en) | 2016-03-24 |
| MX2016001694A (es) | 2016-05-02 |
| GB201314248D0 (en) | 2013-09-25 |
| CN105592857A (zh) | 2016-05-18 |
| US20170119864A1 (en) | 2017-05-04 |
| AR097188A1 (es) | 2016-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276210B1 (en) | Mers-cov vaccine | |
| IL279395A (en) | A vaccine | |
| EP3065716C0 (en) | FORMULATIONS | |
| ZA201604498B (en) | Single vial vaccine formulations | |
| EP2968569A4 (en) | COUGAR FORMULATION | |
| GB201319792D0 (en) | Formulations | |
| GB201301085D0 (en) | Glycoconjugate Vaccine | |
| HK1214951A1 (zh) | 眼用製劑 | |
| GB201320432D0 (en) | Novel formulation | |
| SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
| HK1217206A1 (zh) | 疫苗 | |
| ZA201600027B (en) | Pharmaceutical preparation | |
| GB201322948D0 (en) | Improved formulation | |
| EP2822599A4 (en) | VACCINE | |
| GB2517232B (en) | Formulation | |
| GB201317718D0 (en) | Novel formulation | |
| IL243873A0 (en) | Formulation of a saccharide component | |
| HK1209981A1 (en) | Formulation | |
| IL244316A0 (en) | A new composition of a drug | |
| ZA201506465B (en) | Pharmaceutical preparation | |
| GB201320646D0 (en) | Vaccine | |
| GB201315556D0 (en) | Vaccine | |
| GB201312347D0 (en) | Formulation | |
| GB201317717D0 (en) | Novel formulation |